On Friday, AnaptysBio Inc (NASDAQ: ANAB) was -3.00% drop from the session before settling in for the closing price of $15.00. A 52-week range for ANAB has been $14.20 – $41.31.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 172.96% over the past five years. When this article was written, the company’s average yearly earnings per share was at -0.07%. With a float of $26.01 million, this company’s outstanding shares have now reached $30.43 million.
Let’s look at the performance matrix of the company that is accounted for 117 employees. In terms of profitability, gross margin is 95.8%, operating margin of -257.84%, and the pretax margin is -289.74%.
AnaptysBio Inc (ANAB) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward AnaptysBio Inc stocks. The insider ownership of AnaptysBio Inc is 14.52%, while institutional ownership is 103.68%. The most recent insider transaction that took place on Nov 29 ’24, was worth 250,000. In this transaction Director of this company sold 10,000 shares at a rate of $25.00, taking the stock ownership to the 1,950 shares. Before that another transaction happened on Nov 29 ’24, when Company’s Director proposed sale 10,000 for $25.00, making the entire transaction worth $250,000.
AnaptysBio Inc (ANAB) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.51 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -0.07% per share during the next fiscal year.
AnaptysBio Inc (NASDAQ: ANAB) Trading Performance Indicators
You can see what AnaptysBio Inc (ANAB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 10.23. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.07, a number that is poised to hit -1.62 in the next quarter and is forecasted to reach -5.36 in one year’s time.
Technical Analysis of AnaptysBio Inc (ANAB)
AnaptysBio Inc (NASDAQ: ANAB) saw its 5-day average volume 0.84 million, a positive change from its year-to-date volume of 0.39 million. As of the previous 9 days, the stock’s Stochastic %D was 6.82%. Additionally, its Average True Range was 2.09.
During the past 100 days, AnaptysBio Inc’s (ANAB) raw stochastic average was set at 1.31%, which indicates a significant decrease from 3.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 177.84% in the past 14 days, which was higher than the 103.31% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $24.03, while its 200-day Moving Average is $27.36. Nevertheless, the first resistance level for the watch stands at $15.16 in the near term. At $15.77, the stock is likely to face the second major resistance level. The third major resistance level sits at $16.26. If the price goes on to break the first support level at $14.07, it is likely to go to the next support level at $13.58. The third support level lies at $12.97 if the price breaches the second support level.
AnaptysBio Inc (NASDAQ: ANAB) Key Stats
There are 30,429K outstanding shares of the company, which has a market capitalization of 429.46 million. As of now, sales total 17,160 K while income totals -163,620 K. Its latest quarter income was 30,020 K while its last quarter net income were -32,850 K.
